Business Wire

Taboola Launches “News Feed”, Bringing Continuous-Scroll Experience to the Open Web, Recommending Content, Video, Products and More


Taboola, the leading content discovery platform, today launched the Taboola Feed - a continuous-scrolling feed that is a completely new content discovery experience for advertisers and publishers. Users will now be able to scroll infinitely after reading an article to discover various information including content, in-feed videos, products, app downloads, and more. Taboola also announced New York Daily News as the first publisher partner to test and implement Taboola Feed on its mobile and desktop pages.

This Smart News Release features multimedia. View the full release here:

New York Daily News first to implement Taboola Feed (Photo: Business Wire)

New York Daily News first to implement Taboola Feed (Photo: Business Wire)

Taboola, which currently reaches 1 billion users a month globally, launched this technology to address content consumption habits derived from social media. Taboola Feed provides meaningful value to consumers who are already adapted to a similar experience on social networks, where they currently spend significant time. New York Daily News and other publishers using the Taboola Feed have already seen an increase in revenue and engagement simultaneously. In turn, Taboola Feed offers advertisers an opportunity to reach audiences in a targeted way -- leveraging the same formats that are available at scale on social networks but - adjacent to safe and quality editorial content.

The interface of the Feed surfaces ‘cards’ of different information and formats. The publisher has full control over which cards should be organic (recirculating their own editorial content) and which cards should be sponsored (paid by a marketer, sponsored content, in-feed video, products, apps, etc). The intent is to encourage readers to spend more time on site and within the publisher’s own environment, while continuing to serve content they may be interested in consuming next. Since employing the Taboola Feed on its pages last month, New York Daily News has seen an uplift in revenue of 26 percent, and engagement of 40 percent on mobile.

“User behavior evolves as digital environments evolve. Social media platforms have accustomed readers to the behavior of continuous-scrolling,” said Grant Whitmore, Executive Vice President, Digital, at New York Daily News. “The Taboola Feed mirrors that experience and brings an engaging environment to each article page that was previously only available on social media. We are excited to work with Taboola to pioneer the next evolution of the open web.”

“Imagine an experience like Instagram or Facebook that starts when an article ends on your favorite website. I could not be more excited to completely revolutionize our entire front-end product line on the 10th year of our journey. This marks the end of the “widget economy” and an opportunity to finally streamline the competing priorities publishers have waged for users’ attention throughout their site,” said Adam Singolda, CEO and founder of Taboola. “I’m particularly grateful to have the chance to work with Grant and the team at New York Daily News on this innovative revolution, and I’m confident the internet will look markedly different in years to come, starting with the change we have announced today.”

The new Taboola Feed experience will better enable brands to convey messaging to highly-valued customers on both desktop and mobile and engage in a brand-safe environment. Currently, while social platforms provide high engagement due to format and data, content marketers have very little choice of where their content and videos may appear. The Taboola Feed offers a similar integrated experience - including data to target the right audiences and global -- but placed next to premium and brand safe editorial content.

“I believe the user experience of the open web has to change, and become integrated, evolving from widgets appearing at the top, in mid article, along the right rail and at the bottom of article. - We have a lot to learn from social networks on that front,” continued Singolda. “I also believe advertisers need to have both amazing formats and the ability to target the right audience -- while appearing natively on the best sites and content in a safe environment. Taboola Feed is just the beginning in serving this mission - to deliver scale with brand safety.”

About Taboola

Taboola is the leading discovery platform, serving over 360 billion editorial and video recommendations to over 1 billion unique visitors every month on some of the Web’s most innovative publisher sites, including USA TODAY, Huffington Post, MSN, Business Insider, Chicago Tribune and The Weather Channel. Headquartered in New York City, Taboola also has offices in Los Angeles, London, Tel Aviv, New Delhi, Bangkok, São Paulo, Beijing, Shanghai, Seoul, Istanbul, Sydney and Tokyo. Publishers, marketers, and agencies leverage Taboola to retain users on their sites, monetize their traffic, and distribute their content to drive high-quality audiences. Learn more at and follow @taboola on Twitter.

Contact information

Media Contact
Karen Germ, 480-332-7949

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on